The authors wish to make the following corrections to this paper [1]. There are typos in the numbers associated with the compound LDN/OSU 0212320. The numbers were incorrectly typed as LDN/OSU 0232120 in some areas of the manuscript and Supplementary Materials. The correct information is:
In the fifth paragraph of Introduction:
In 2014, Kong and colleagues characterized a compound, LDN/OSU 0212320 (LDN), that upregulated GLT-1 protein levels at the post-transcriptional level as fast as two hours after injection.
In the sub-title of Results:
3.1. Effect of LDN/OSU 0212320 Given 24 h before Focal Ischemia on Stroke Outcomes in Male and Female Mice
3.2. Effect of LDN/OSU 0212320 Given 2 h after Focal Ischemia on Stroke Outcomes in Male and Female Mice
3.3. Effect of LDN/OSU 0212320 on GLT-1 Protein Levels in Brains of Male and Female Mice
In Figure 4 caption:
Expression of GLT-1 in brains after a single injection of vehicle or LDN/OSU 0212320 (LDN).
In Figure 5 caption:
Expression of GLT-1 in female brain cortex after different doses of LDN/OSU 0212320 (LDN).
In the Supplementary Materials:
The following are available online at www.mdpi.com/2076-3425/11/1/76/s1, Figure S1: Expression of GLT-1 in male brains after a single injection of vehicle or LDN/OSU 0212320 (LDN); Figure S2: Expression of GLT-1 in female brains after a single injection of vehicle or LDN/OSU 0212320 (LDN); Figure S3: Expression of GLT-1 in female brain cortex after different doses of LDN/OSU 0212320 (LDN).
In the supplementary file, the figure caption should be:
Supplemental Figure S1: Expression of GLT-1 in male brains after a single injection of vehicle or LDN/OSU 0212320 (LDN).
Supplemental Figure S2: Expression of GLT-1 in female brains after a single injection of vehicle or LDN/OSU 0212320 (LDN).
Supplemental Figure S3: Expression of GLT-1 in female brain cortex after different doses of LDN/OSU 0212320 (LDN).
The authors would like to apologize for any inconvenience caused to the readers by these changes.
Footnotes
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Reference
- 1.Tejeda-Bayron F.A., Rivera-Aponte D.E., Malpica-Nieves C.J., Maldonado-Martínez G., Maldonado H.M., Skatchkov S.N., Eaton M.J. Activation of Glutamate Transporter-1 (GLT-1) Confers Sex-Dependent Neuroprotection in Brain Ischemia. Brain Sci. 2021;11:76. doi: 10.3390/brainsci11010076. [DOI] [PMC free article] [PubMed] [Google Scholar]